The Holy Grail sought for more than two decades by interventional cardiology has been proof that minimally invasive, percutaneous coronary intervention (PCI) procedures can perform as well or better than the gold-standard of coronary artery bypass graft surgery (CABG).


The Holy Grail sought for more than two decades by interventional cardiology has been proof that minimally invasive, percutaneous coronary interventions (PCI) procedures can perform as well or better than the gold-standard of coronary artery bypass graft surgery (CABG). Abbott Vascular is now pitting its Xience V stent against CABG in a new trial.

October 7, 2011 — There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity. To get this information out, the American Society of Echocardiography (ASE) is preparing a guideline document outlining the best way to evaluate cancer patients. ASE has also funded a research study to enhance identification of patients who are at risk.

October 7, 2011 – ValveXchange Inc., has performed successful first-in-man (FIM) surgeries demonstrating the practicality and advantages of its novel Vitality two-part heart valve system. Two renowned United States cardiac surgeons, Lars Svensson, M.D., Ph.D., of The Cleveland Clinic and W. Randolph Chitwood, M.D. of The East Carolina Heart Institute, performed the surgeries; they were working with Adrian Ebner, M.D. at his facilities in Asuncion, Paraguay.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now